Disproportionately high rate of epileptic seizure in patients abusing dextropropoxyphene dextropropoxyphene

American Journal on Addictions

Volumn 18, Issue 5, 2009, Pages 417-421

  Basu, Debasish ^a   Banerjee, Anindya ^a   Harish, Thippeswamy ^a   Mattoo, Surendra K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; HYPNOTIC SEDATIVE AGENT; NICOTINE; OPIATE; PENTAZOCINE;

ABSENCE; ADULT; ARTICLE; ATONIC SEIZURE; BIPOLAR DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FOCAL EPILEPSY; GASTROINTESTINAL DISEASE; GRAND MAL SEIZURE; HUMAN; HYPERTENSION; INDIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; OPIATE ADDICTION; PSYCHOSIS; RETROSPECTIVE STUDY; SEIZURE; TERTIARY HEALTH CARE; TONIC CLONIC SEIZURE;

ADULT; AGE FACTORS; COMORBIDITY; DEXTROPROPOXYPHENE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; HUMANS; MALE; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; TIME FACTORS;

EID: 71049173275     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490903077697     Document Type: Article

References (17)

1. Miller RR, Feingold A, Paxinos J. Propoxyphene hydrochloride-a critical review. JAMA. 1970;213:996-1006
2. Dextropropoxyphene. In: Sweetman S, ed.Martindale: The complete drug reference, 35th ed. Pharmaceutical Press (Publications division of the Royal Pharmaceutical Society of Great Britain), London: 2007
3. Young RJ. Dextropropoxyphene overdosage: Pharmacological considerations and clinical management. Drugs. 1983;26:70-79
4. Ramsay BC. Complete nerve deafness after abuse of co-proxamol. Lancet. 1991;338:446-447
5. Rosenberg WMC, Ryley NG, Trowell JM, McGee JO, Chapman RW. Dextropropoxyphene induced hepatotoxicity: a report of nine cases. J Hepatol. 1993;19:470-474
6. Young RJ, Lawson AAH. Distalgesic poisoning-cause for concern. BMJ. 1980;12:1045-1047
7. Madsen SP, Strom J, Reiz S, Sorensen BM. Acute propoxyphene self-poisoning in 222 consecutive patients. Acta Anaesthesiol Scand. 1984;28:661-665
8. Ng B, Alvear M. Dextropropoxyphene addiction-a drug of primary abuse. Am J Drug Alcohol Abuse. 1993;19:153-158
9. Saboory E, Derchansky M, Ismaili M, et al. Mechanisms of morphine enhancement of spontaneous seizure activity. Anesth Analg. 2007;105:1729-1735
10. Gutstein HB, Akil H. Opioid analgesics. In: Brunton L, ed. Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005:547-590
11. Steinhauer HB, Hertting G. Lowering of the convulsive threshold by nonsteroidal anti-inflammatory drugs. Eur J Pharmacol. 1981;69:199-203
12. Shrivastava MP, Makde SD, Paranjpe BD. Interaction of ciprofloxacin with diclofenac and paracetamol in relation to its epileptogenic effect. Indian J Physiol Pharmacol. 1997;41:164-166
13. Deng JF, Spyker DA, Rall TW, Steward O. Reduction in caffeine toxicity by acetaminophen. J Toxicol Clin Toxicol. 1982;19:1031-1043
14. Rathlev NK, Ulrich AS, Delanty N, D'Onofrio G. Alcohol-related seizures. J EmergMed. 2006;31:157-163
15. Little HJ. The benzodiazepines: anxiolytic and withdrawal effects. Neuropeptides. 1991;19 Suppl:11-14
16. Barkin RL, Barkin SJ, Barkin DS. Propoxyphene (dextropropoxyphene): a critical reviewof aweak opioid analgesic that should remain in antiquity. Am J Ther. 2006;13:534-542
17. Willens JS. Consumer group urges Food and Drug Administration to ban Darvon (editorial). Pain Manag Nurs. 2006;7:43